1-12 of 12
Axel Matzdorff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study to Investigate the Efficacy and Safety of Eltrombopag in Combination with Dexamethasone As First-Line Treatment in Adults Patients with Newly Diagnosed Primary ITP (XPAG-ITP)

Mascha Binder, Axel Matzdorff, Falk Nimmerjahn, Mathias Rummel, Oliver Meyer, Tamara Tesanovic, Tanja Sauer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3151.
https://doi.org/10.1182/blood-2021-147218
Published: 2021
Journal Articles

Rationale and Design of an Observational Multicenter Study to Evaluate the Use and Effectiveness of Avatrombopag in Adult Patients with Immune Thrombocytopenia: The Adopt Study

Vickie McDonald, Axel Matzdorff, Åsa Mellbring, Jameel Nazir, Daniel Lindqvist, Elena Santagostino
Journal: Blood
Blood (2021) 138 (Supplement 1): 4210.
https://doi.org/10.1182/blood-2021-144690
Published: 2021
Journal Articles

Chronic Neutrophilic Leukemia - Stem Cell Transplantation in a Very Young Patient

Axel Matzdorff, MDPhD, Martin Duckert, MD, Andrzej Wojciechowski, MD, Annerose Meier, MD, Frank Dombrowski, MD PhD, Olaf Joachim Hopfer, MD, Michael G. Kiehl, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-134420
Published: 2020
Journal Articles

A Phase II Study to Investigate the Efficacy and Safety of Eltrombopag in Combination with Dexamethasone As First-Line Treatment in Adult Patients with Newly Diagnosed Primary ITP (XPAG-ITP)

Axel Matzdorff, MDPhD, Mascha Binder, MD, Falk Nimmerjahn, PhD, Oliver Meyer, MD PhD, Mathias J. Rummel, MD PhD, Tamara Tesanovic, PhD, Tanja Sauer
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-134318
Published: 2020
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 3 rd Interim Analysis of the German Non-Interventional Trial RISA

Oliver Meyer, MD PhD, Martina Stauch, Dietrich Kaempfe, MD, Rudolf Schlag, Marcel Reiser, Eyck von der Heyde, Andreas Josting, Margarete Plath, Nadine Ballerstädt, Petra Stark-Lorenzen, Axel Matzdorff, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-134542
Published: 2020
Journal Articles

From Fatigue Surveys to Survey Fatigue - Notes from Daily Hematology Practice

Axel Matzdorff, MDPhD, Jens U. Rüffer, MD PhD, Oliver Meyer, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39.
https://doi.org/10.1182/blood-2020-134331
Published: 2020
Journal Articles

ITP World Impact Survey (I-WISh) 2.0: Further Exploration of the Impact of ITP on Patients

Waleed Ghanima, Drew Provan, Nichola Cooper, MD, Axel Matzdorff, MDPhD, Ming Hou, Cristina Santoro, Mervyn Morgan, Caroline Kruse, Francesco Zaja, Leron Lahav, Yoshiaki Tomiyama, Michal Winograd, Barbara Lovrencic, Tom Bailey, MSci, Jens Haenig, James B. Bussel
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-136651
Published: 2020
Journal Articles

The New ASH ITP-Guideline Recommendations - Marching Separately, Beating Together

Axel Matzdorff, MDPhD, Oliver Meyer, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-134412
Published: 2020
Journal Articles

Variable Support Towards ASCO Recommendations for Venous Thromboembolism (VTE) Prophylaxis and Treatment in Patients with Cancer

Axel Matzdorff, MD PhD, Uwe Schwindel, MD, Michael Mueller, Hans Joachim Hutt, MD
Journal: Blood
Blood (2015) 126 (23): 5564.
https://doi.org/10.1182/blood.V126.23.5564.5564
Published: 2015
Journal Articles

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

Clinical Trials & Observations
Michela Tassara, Konstanze Döhner, Peter Brossart, Gerhard Held, Katharina Götze, Heinz-A. Horst, Mark Ringhoffer, Claus-Henning Köhne, Stephan Kremers, Aruna Raghavachar, Gerald Wulf, Heinz Kirchen, David Nachbaur, Hans Günter Derigs, Mohammed Wattad, Elisabeth Koller, Wolfram Brugger, Axel Matzdorff, Richard Greil, Gerhard Heil, Peter Paschka, Verena I. Gaidzik, Martin Göttlicher, Hartmut Döhner, Richard F. Schlenk
Journal: Blood
Blood (2014) 123 (26): 4027–4036.
https://doi.org/10.1182/blood-2013-12-546283
Published: 2014
Includes: Supplemental data
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Dohner, MD, Martina Kerz, Francisco del Valle, MD, Björn Heydrich, MD, Ingo Schmidt-Wolf, MD, Hans Pralle, MD, Katharina Götze, MD, Elisabeth Koller, MD, David Nachbaur, MD, Hans G. Mergenthaler, MD, Walter Fiedler, MD, Detlef Haase, MD, Stephan Kremers, MD, Matthias Theobald, MD, Axel Matzdorff, MD, Arnold Ganser, MD, Hartmut Dohner, MD
Journal: Blood
Blood (2006) 108 (11): 1949.
https://doi.org/10.1182/blood.V108.11.1949.1949
Published: 2006
Journal Articles

Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study.

Christian Langer, MD, Eva Lengfelder, MD, Jurgen Thiele, MD, Hans M. Kvasnika, MD, Heike Pahl, PhD, Axel Matzdorff, MD, Barbara Stade, Stefanie Schauer, Heinz Gisslinger, MD, Hartmut Dohner, MD, Martin Griesshammer, MD
Journal: Blood
Blood (2004) 104 (11): 1522.
https://doi.org/10.1182/blood.V104.11.1522.1522
Published: 2004